MedPath

Arm function and quality of life after trimodal treatment of sulcus superior tumour (SST)

Recruiting
Conditions
Pancoast tumour
10029107
10038737
Registration Number
NL-OMON34727
Lead Sponsor
Heelkunde VUmc
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Surgical resection of sulcus superior tumour in VUmc after induction treatment with chemoradiatiotherapy
Treated after 01-01-2002
Age at treatment between 18 and 80 years

Exclusion Criteria

Current functional status ECOG >2 (confined to bed or chair >50% of waking hours)
Armfunction not assessable due to causes unrelated to locoregional treatment for SST (e.g. CVA, trauma, brain metastasis)

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Questionnaire DASH (Disability of Arm, Shoulder and Hand)<br /><br>Questionnaire Quality of life (SF-36)<br /><br><br /><br>Objective measurement of arm- and shoulderfunction (treated and untreated<br /><br>extremity)<br /><br>A.R.A.-test: Action research arm-test<br /><br>9-hole peg-test<br /><br>R.O.M.-test: Range Of Motion-test<br /><br>FAT-test: Frenchay Arm Test </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Age<br /><br>Symptomatic period before start treatment<br /><br>Radiotherapy dose<br /><br>chemotherapy scheme<br /><br>clinical tumour stage (cTNM)<br /><br>pathological tumour stage (pTNM)<br /><br>Time interval between induction and surgery<br /><br>Time interval between surgery and study date<br /><br>Right or left handedness</p><br>
© Copyright 2025. All Rights Reserved by MedPath